Area of research
Molecular Biology · Plant Science
Research interest
Research interests include Biochemical and Structural Characterization, Glycosylation and Glycoproteins Research, Chemical Synthesis and Analysis, and Phytoplasmas and Hemiptera pathogens.
Resistance is futile: targeting multidrug-resistant bacteria with <i>de novo</i> Cys-rich cyclic polypeptides.
Lipidation of a bioactive cyclotide-based CXCR4 antagonist greatly improves its pharmacokinetic profile in vivo.
Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development.
SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
Engineered Cyclotides with Potent Broad in Vitro and in Vivo Antimicrobial Activity.
Chemical Synthesis of a Potent Antimicrobial Peptide Murepavadin Using a Tandem Native Chemical Ligation/Desulfurization Reaction.
Cover Feature: Engineered Cyclotides with Potent Broad in Vitro and in Vivo Antimicrobial Activity (Chem. Eur. J. 49/2021)
Recombinant Expression of Cyclotides Using Expressed Protein Ligation.
The Potential of the Cyclotide Scaffold for Drug Development.
Biotechnological Applications of Protein Splicing.
Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions.
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature
Design of a Novel Cyclotide-Based CXCR4 Antagonist with Anti-Human Immunodeficiency Virus (HIV)-1 Activity